Stephen Chan, M.D., Ph.D.

First-In-Class Precision Therapy for Pulmonary Hypertension.

Stephen Chan, MD, PhD, is a physician-scientist and cardiologist. He serves as Professor and Vitalant Chair in Vascular Medicine and Director of the Vascular Medicine Institute at the University of Pittsburgh School of Medicine. He studies mechanisms of pulmonary vascular disease and heart-lung-brain communication and has published in Science, Cell, Cell Metab, J Clin Invest, Sci Transl Med, Circulation, and Circ Res, among others. Dr. Chan has served as mentor for >35 trainees with success across career development and independent research funding. Dr. Chan directs a clinical program of excellence in pulmonary hypertension. He has founded a humanitarian telemedicine organization serving east Africa as well as biotech companies developing heart and lung disease therapies. Dr. Chan was elected to the Association of University Cardiologists, Association of American Physicians, and American Society of Clinical Investigation (ASCI), where he is JCI Insight Deputy Editor. Dr. Chan was elected as ASCI Vice President and will become President in 2027.